| Literature DB >> 28292775 |
Jin Ma1, Honghui Li1, Xiaohu Ding1, Silvia Tanumiharjo1, Lin Lu1.
Abstract
PURPOSE: To evaluate the efficacy of a combined macular buckle under direct vision and 23-gauge pars plana vitrectomy (PPV) with internal limiting membrane (ILM) peeling in refractory macular hole retinal detachment (MHRD) with extreme high axial myopia.Entities:
Keywords: Macula; Retina
Mesh:
Year: 2017 PMID: 28292775 PMCID: PMC5629954 DOI: 10.1136/bjophthalmol-2016-310123
Source DB: PubMed Journal: Br J Ophthalmol ISSN: 0007-1161 Impact factor: 4.638
Figure 1Surgical procedure of macular buckle and postoperative outcome in a same case. (A) The buckling element was made of a piece of silicone tire (6×15 mm) sewn with an encircling silicone band (3 mm width). (B) Buckle was passed underneath the inferior oblique muscle. (C) Congested and tortuous vortex veins during surgical process. (D) After pars plana vitrectomy (PPV) and internal limiting membrane (ILM) peeling around macular hole (thin arrow), the buckle indentation initially located at equator (thick arrow). (E) Episcleral silicone (thick arrow) tire was moved to the posterior pole of the eyeball gradually under direct vision. (F) Location of buckle was adjusted under direct vision until macular indentation (thick arrow) was under macular hole (thin arrow). (G) Preoperative fundus photograph with macular hole retinal detachment (MHRD) (thin arrow). (H) 24 months postoperative fundus photograph with retina reattachment. I. Preoperative (upper) and 24 months postoperative (down) optical coherence tomography examination with unclosed macular hole and flattened staphyloma.
Figure 2The schematic for surgical procedure. The encircling band was fixed and sutured on the sclera of nasal quadrant (thick arrows). The silicone band and buckle (dashed line) were located on the nasal side of inferior oblique muscle termination (thin arrow). The white arrow points to the macular hole.
Demographic and preoperative ophthalmic data of the study participants
| Characteristics | Group 1 | Group 2 | p Value |
|---|---|---|---|
| No. of patients (eyes) | 52 (52) | 46 (46) | |
| Gender (female/male) | 24/28 | 22/24 | 0.869* |
| Age (years) | 48.70 (10.21) | 53.11 (13.52) | 0.31† |
| Refraction (dioptres) | |||
| Mean (SD) | −21.20 (4.05) | −23.62 (4.72) | 0.32† |
| Median (p25; p75) | 21.50 (−19.50; −25.50) | −23 (−20; −25) | |
| (min to max) | (−17 to −30) | (−18 to −29) | |
| Axial length (mm) | 0.270† | ||
| Mean (SD) | 32.73 (2.42) | 33.98 (2.35) | |
| Median (p25; p75) | 33.53 (31.00; 34.00) | 33.05 (31.50; 34.05) | |
| (min to max) | 30.10 to 36.00 | 30.00 to 37.50 | |
| BCVA (LogMAR) | |||
| Mean (SD) | 1.67 (0.49) | 1.61 (0.53) | 0.404† |
| Median (p25; p75) | 1.602 (1.00; 1.903) | 1.602 (0.80; 1.903) | |
| (min to max) | 0.70 to 2.30 | 0.50 to 2.30 | |
| Retinoschisis-like feature, n (%) | 25 (48.10%) | 26 (56.50%) | 0.403* |
| Lens status, n (%) | 0.194* | ||
| Aphakic | 0 | 0 | |
| Phakic | 26 (50%) | 29 (63%) | |
| Pseudophakic | 26 (50%) | 17 (37%) | |
| IOP (mm Hg) | |||
| Mean (SD) | 14.60 (3.21) | 15.12 (3.30) | 0.306† |
| Median (p25; p75) | 14.9 (13.8; 16.3) | 15.2 (13.5; 16.1) | |
| (min to max) | 12.1 to 17.5 | 13.0 to 17.5 | |
| Symptom duration (months) | |||
| Mean (SD) | 4.78±3.32 | 6.10±4.21 | 0.672† |
| Median (p25; p75) | 4.5 (2.5; 6.0) | 5.5 (3.5; 7.0) | |
| (min to max) | 0.5 to 10.5 | 1 to 12 | |
| PVD presence, n (%) | 11 (21.15%) | 7 (15.22%) | 0.449* |
| PVR (posterior) | |||
| Grade B | 44 (88.46%) | 40 (91.30%) | 0.741* |
| Grade C | 8 (11.54%) | 6 (8.70%) | |
| Grades of chorioretinal degeneration§, n (%) | 0.609* | ||
| Grade M4 | 23 (44.23%) | 18 (39.13%) | |
| Grade M5 | 29 (55.77%) | 28 (60.87%) | |
| Grades of posterior staphyloma¶, n (%) | |||
| Grade 4 | 52 (100%) | 46 (100%) | |
| Area of retinal detachment | 0.418* | ||
| Within staphyloma | 24 (46.15%) | 25 (54.35%) | |
| Beyond staphyloma | 28 (53.85) | 21 (45.65%) | |
Group 1=treated with PPV and ILM peeling; group 2=treated with PPV and ILM peeling combined with macular buckle.
*χ2 test.
†Mann-Whitney U test.
§By Avila et al.22
¶By Steidl et al.23
BCVA, best-corrected visual acuity; ILM, internal limiting membrane; IOP, Intraocular pressure; LogMAR, logarithm of minimum angle of resolution; PPV, pars plana vitrectomy; PVD, posterior vitreous detachment; PVR, proliferative vitreous retinopathy.
Figure 3Anatomical outcome comparison between two groups. The difference between the two groups were significant in the initial retinal reattachment (A) at 12 months postoperatively (*p<0.05, Fisher's exact test), and in macular hole closure rate (B) at 3, 12, 18 and 24 months postoperatively (*p<0.05, χ2 test).
Changes in preoperative and postoperative BCVA and retina status of two groups
| Preoperation and follow-up (months) | Group 1 (no. of eyes, LogMAR BCVA (mean±SD)) | Group 2 (no. of eyes, LogMAR BCVA (mean±SD)) | p Value of initial success cases (group 1 vs group 2) | p Value† of BCVA in initial success (group 1 vs group 2) | ||
|---|---|---|---|---|---|---|
| Initial success | Initial failure | Initial success | Initial failure | |||
| Preoperation | 52, (1.67±0.49) | 46 (1.61±0.53) | ||||
| 1 | 52 (1.31±0.45) | 0 | 46 (1.46±0.43) | 0 | 0.036* | |
| 3 | 50 (1.26±0.31) | 2 (2.10±0.28) | 46 (1.35±0.37) | 0 | 0.502‡ | 0.080 |
| 6 | 46 (1.13±0.33) | 6 (1.95±0.39) | 45 (0.93±0.30) | 1 (1.60) | 0.161§ | 0.012* |
| 9 | 43 (1.11±0.37) | 9 (1.95±0.39) | 43 (0.90±0.28) | 3 (1.40±0.17) | 0.103§ | 0.010* |
| 12 | 40 (1.13±0.28) | 12 (2.11±0.45) | 43 (0.90±0.32) | 3 (1.40±0.17) | 0.022*§ | 0.007* |
| 18 | 39 (1.22±0.35) | 13 (2.02±0.41) | 41 (0.98±0.29) | 5 (1.36±0.13) | 0.070§ | 0.007* |
| 24 | 39 (1.30±0.43) | 13 (2.02±0.41) | 41 (1.05±0.40) | 5 (1.36±0.13) | 0.070§ | 0.007* |
*p<0.05.
†Wilcoxon matched pairs signed rank test.
‡Fisher's exact test.
§χ2 test.
BCVA, best-corrected visual acuity; LogMAR, logarithm of minimum angle of resolution.
Figure 4Preoperative and postoperative evaluation of best-corrected visual acuity (BCVA) (LogMAR) (A), axial length (B) and intraocular pressure (IOP) (C) (Wilcoxon matched pairs signed rank test). The different change between the two groups were significant in BCVA (LogMAR) of initial retinal reattached cases at 1, 6, 9, 12, 18, 24 months postoperatively (p<0.05), in axial length of all eyes at each follow-up point (p<0.05) and in IOP of all eyes at 1 month postoperatively (p=0.041).